Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4500881000168117 | epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride monohydrate 170 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL gel, 5 x 4 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4500891000168119 | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, 5 x 4 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, 5 x 4 mL vials | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, 5 x 4 mL vials | has MPUU | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, vial | false | Inferred relationship | Some | 1731585991 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | Is a | False | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, 5 x 4 mL vials | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR